Skip to main content

Table 1 Clinicopathologic characteristics according to pre-sarcopenia status

From: Prognostic role of pre-sarcopenia and body composition with long-term outcomes in obstructive colorectal cancer: a retrospective cohort study

  Non-pre-sarcopenia (N = 143) Pre-sarcopenia (N = 71) P
Sex, male (%) 75 (52.1) 51 (70.8) 0.008
Age (years), > 70 (%) 29 (20.1) 21 (29.2) 0.138
Location (%)    0.958
 Right 32 (22.2) 16 (22.2)  
 Left 94 (65.3) 46 (63.9)  
 Rectum 18 (12.5) 10 (13.9)  
Preoperative CEA, ≥ 5 (%) 55 (40.4) 26 (40.0) 0.952
Neutrophil lymphocyte ratio, ≥ 5 (%) 54 (76.1) 17 (23.9) 0.932
ASA (%)    0.466
 I 42 (29.2) 18 (25.0)  
 II 91 (63.2) 46 (63.9)  
 III 11 (7.6) 7 (9.7)  
 IV 0 (0.0) 1 (1.4)  
Operation methods (%)    0.530
 Laparoscopy 57 (39.6) 23 (31.9)  
 Open 75 (52.1) 43 (59.7)  
 Conversion 12 (8.3) 6 (8.3)  
Stage (%)    0.092
 II 48 (33.3) 16 (25.0)  
 III 96 (66.7) 56 (77.8)  
CONUT score 2.6 ± 2.2 3.2 ± 2.3 0.181
LN harvest 27.4 ± 14.0 26.8 ± 15.1 0.781
Tumor size (cm) 5.5 ± 2.1 5.6 ± 2.2 0.791
Lymphatic invasion, Yes (%) 92 (63.9) 44 (61.1) 0.690
Vascular Invasion, Yes (%) 22 (15.3) 13 (18.1) 0.601
Perineural invasion, Yes (%) 52 (36.1) 28 (38.9) 0.690
Differentiation (%)    0.840
 Well 9 (6.3) 4 (5.6)  
 Moderate 125 (86.8) 63 (87.5)  
 Poor 10 (6.9) 5 (6.9)  
  1. CEA carcinoembryonic antigen, ASA American Society of Anesthesiologist physical status, LN lymph node, CONUT Controlling Nutritional Status